England's MS risk sharing scheme fails, researchers find - update
This article was originally published in SRA
Executive Summary
A risk sharing scheme set up in 2002 by the Department of Health in England and Wales to establish the cost-effectiveness of multiple sclerosis drugs is a “costly failure” for the National Health Service and should not be continued, claim researchers in articles published in the BMJ1.